RISHABH GULATI

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology SILVERDALE, WA NPI 1649688698

General Payments — all program years on this page

$2,561.55

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 79
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,153.73 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,153.7339

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $661.3818
2019 $399.6711
2020 $149.373
2022 $106.925
2023 $90.483
2024 $1,153.7339

Records — PY2024 (39)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078830903 Janssen Biotech, Inc. $20.66 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078830907 Janssen Biotech, Inc. $10.09 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078831015 Janssen Biotech, Inc. $10.11 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078861769 Janssen Scientific Affairs, LLC $110.74 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101192219 Celgene Corporation $18.66 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101192229 Celgene Corporation $21.22 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101192239 Celgene Corporation $19.39 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101192249 Celgene Corporation $20.08 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103849430 ABBVIE INC. $27.62 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103849432 ABBVIE INC. $4.67 09/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103849434 ABBVIE INC. $29.01 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103849436 ABBVIE INC. $7.56 11/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103849438 ABBVIE INC. $27.10 11/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103849440 ABBVIE INC. $29.87 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103849442 ABBVIE INC. $9.71 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108471692 Olympus America Inc. $17.90 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114061539 Regeneron Healthcare Solutions, Inc. $27.72 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131757540 PFIZER INC. $24.00 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132814192 ERBE USA INC $15.89 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135391389 Lilly USA, LLC $24.07 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137564824 Takeda Pharmaceuticals U.S.A., Inc. $26.70 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137564828 Takeda Pharmaceuticals U.S.A., Inc. $18.40 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137564831 Takeda Pharmaceuticals U.S.A., Inc. $30.49 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139826618 GENZYME CORPORATION $23.40 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139826668 GENZYME CORPORATION $28.36 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139826672 GENZYME CORPORATION $33.34 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139826676 GENZYME CORPORATION $125.10 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144168179 Madrigal Pharmaceuticals $115.79 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147005789 AIMMUNE THERAPEUTICS, INC. $15.55 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151068417 Phathom Pharmaceuticals, Inc. $18.34 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151068419 Phathom Pharmaceuticals, Inc. $0.69 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151068421 Phathom Pharmaceuticals, Inc. $90.91 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151068423 Phathom Pharmaceuticals, Inc. $31.18 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151068425 Phathom Pharmaceuticals, Inc. $20.05 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153469959 Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.37 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153500427 Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.12 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153637432 Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.64 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153703954 Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.00 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153757863 Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.23 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.